MLI Coupon Plus (MLI 2017 - 05)
The product is not available for subscription / This product is open to subscription
The Market Linked Investment (MLI) is a 3 year Deferred Purchase Agreement product which is linked to the performance of shares in two NYSE-listed companies: Eli Lilly and Company(“LLY”) and Bristol-Myers Squibb Company (“BMY”), one LSE-listed company: AstraZeneca PLC (“AZN”) and one Xetra-listed company: Bayer AG (“BAYN”), each a Reference Asset, and together the Reference Assets. The MLI offers the potential for quarterly income payment of a fixed percentage. The MLI includes a Call Event Observation feature, an Early Maturity feature and a Knock-In Event feature which may terminate the product early or cause the loss of some or all of your investment amount.
Investors should read and understand the contents of the relevant Product Disclosure Statement, including the risks of investing in the MLI, and seek any relevant independent advice before making any investment decision.
For further information on structured financial products contact the Citigroup Structured Products Service Centre.